How Tesamorelin Price Per Mg Changes With Vial Concentration

Tesamorelin price per mg tracks the total milligram strength printed on a vial’s label, not the concentration a buyer creates after adding bacteriostatic water. Those are two different numbers that get conflated often: “vial strength” is fixed by the supplier and set at the time of manufacture, while “concentration” is a downstream figure that only exists once a researcher reconstitutes the lyophilized powder with a chosen volume of diluent. Understanding which one actually drives cost per milligram makes it much easier to compare listings across sources.

Vial Strength Versus Reconstitution Concentration

A vial’s strength is the total mass of peptide inside it, expressed in milligrams, and it is set before the vial ever reaches a buyer. A listing for a 5 mg vial contains 5 mg of tesamorelin whether it sits on a shelf unreconstituted or gets mixed into solution. Concentration, on the other hand, is mg divided by the volume of bacteriostatic water added, and it is entirely up to whoever reconstitutes the vial. The same 5 mg vial can become a 2.5 mg/mL solution with 2 mL of diluent or a 5 mg/mL solution with 1 mL of diluent. The total mass of peptide, and therefore the total amount paid for it, has not changed either way.

This distinction matters because “vial concentration” in cost discussions is frequently used loosely to mean vial strength — the mg amount printed on the label — rather than the mg/mL figure that only appears after mixing. Price per mg is calculated against the labeled strength, so it is set the moment a supplier prices the vial, well before any water touches the powder.

How Price Per Mg Is Calculated

Price per milligram is simply the listed price divided by the labeled mg strength. A source selling a 5 mg vial for $60 is pricing tesamorelin at $12.00 per mg. A source selling a 10 mg vial for $95 is pricing it at $9.50 per mg. A 15 mg vial at $132 works out to $8.80 per mg. The table below illustrates how price per mg tends to move as labeled vial strength increases, using representative figures rather than any single source’s current listing.

Vial strength	Illustrative price	Price per mg
5 mg	$60.00	$12.00
10 mg	$95.00	$9.50
15 mg	$132.00	$8.80

The pattern in this kind of table is common across peptide listings generally: larger vial strengths tend to carry a lower price per mg, similar to bulk pricing in other product categories. That relationship is not guaranteed for every supplier, since packaging, sourcing, and testing overhead all factor into how a given source sets its price, but it is a useful baseline to check a listing against.

Working Through Reconstitution Without Changing Cost

Because concentration is set by the buyer, not the supplier, it never enters the price-per-mg calculation. It does, however, change what a given volume on a syringe represents, which is where confusion about “price per mg changing” often comes from.

Take that same 5 mg vial priced at $60, or $12.00 per mg. If it is reconstituted with 2 mL of bacteriostatic water, the concentration is 5 mg ÷ 2 mL = 2.5 mg/mL. On a U-100 insulin syringe, where 1 mL equals 100 units, that means 100 units of solution contains 2.5 mg, so 1 mg corresponds to 100 ÷ 2.5 = 40 units. If the same vial is instead reconstituted with 1 mL of water, the concentration doubles to 5 mg ÷ 1 mL = 5 mg/mL, and 100 units now contains 5 mg, meaning 1 mg corresponds to 100 ÷ 5 = 20 units.

Neither reconstitution choice changes what was paid for the vial or the $12.00-per-mg figure calculated from the label. What changes is only how much solution volume corresponds to a given mg amount once the powder is in solution. A source’s price per mg is a property of the vial as sold; the mg/mL concentration is a property of how the buyer chose to prepare it afterward. Treating the two as the same number is the most common error in comparing listings across sources, since a lower mg/mL concentration can look like a “better deal” when it has no bearing on cost at all.

Why Listings Present Strength Differently

Sources vary in how clearly they separate these two figures. A well-documented listing states the labeled mg strength, the total vial price, and leaves reconstitution volume to the researcher, along with a certificate of analysis confirming the actual peptide content matches the label. A listing that only advertises a concentration figure without stating the underlying vial strength and total price makes it harder to calculate price per mg independently, since the buyer has to reverse-engineer the math from whatever reconstitution volume the source assumed.

This is one reason COA transparency matters when tesamorelin cost is being tabulated across sources. A COA that verifies actual mg content against the labeled strength confirms the price-per-mg figure is meaningful in the first place; without it, the labeled strength used for that calculation is unverified. Researchers sourcing tesamorelin listing have a firmer basis for comparing price per mg across listings than researchers working from concentration claims alone, since that listing states vial strength and price separately from any reconstitution guidance, keeping the two figures from being conflated.

Classification Context

Tesamorelin belongs to the broader class of growth hormone-releasing factor analogs, a category whose gene-level regulation has been studied for decades. Foundational work on how growth hormone-releasing factor influences growth hormone gene transcription, described in research on transcriptional regulation of growth hormone gene expression by growth hormone-releasing factor, along with related findings on hormonal regulation of growth hormone gene transcription by growth hormone-releasing factor, established the mechanistic basis for this class of molecules long before synthetic analogs like tesamorelin were manufactured for research use. That background does not affect pricing directly, but it explains why tesamorelin is grouped with GHRH analogs when suppliers organize their catalogues and set relative pricing across that category.

For anyone working through reconstitution math on their own vials, a dosing and dilution calculator can cross-check concentration and volume figures independently of the arithmetic shown here.

Summary

Price per mg is a function of labeled vial strength and total price, fixed at the point of sale. Reconstitution concentration is a separate, buyer-controlled figure that changes how much solution volume corresponds to a given mg amount but never changes what was paid per milligram. Keeping these two figures distinct, and checking that a source’s labeled strength is backed by a COA, is what makes price-per-mg comparisons across tesamorelin listings meaningful rather than misleading.